Riskpilot← Back to searchSign inGet full accessFULMED AS
ASActiveOrg 995556375Grensen 9, 0159 OsloEngineering activities and related technical consultancy · NACE 7112Est. 20100 employees
Revenue 2020
NOK 0
EBITDA margin
—
+99% vs 2019
Equity ratio
-515.4%
Financial strength
Net profit 2020
NOK -376
+99% vs 2019
| Revenue | NOK 0 | — |
| EBITDA | NOK -374 | +99% |
| Net profit | NOK -376 | +99% |
| Total assets | NOK 166K | +0% |
| Equity | NOK -858K | +0% |
| Employees | 0 | — |
Legal name
FULMED AS
Org number
995556375
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
27. mai 2010
Share capital
NOK 104 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikle, produsere og selge produkter til å bekjempe lus og andre skadedyr i marine miljøer enten de er i saltvann eller ferskvann. Selskapet kan også eie aksjer eller eierandeler i andre selskaper samt alt annet som står i forbindelse med formålet definert i avsnittet over.
Address
Grensen 9, 0159 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 47 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −468 | 1 | −0 | −5 | −0 | −0 |
| EBITDA | −5 | −11 | 42 | −38 | −57 | −499 | −10 | −50 | −253 | −32 | −0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −5 | −11 | 42 | −38 | −57 | −499 | −10 | −50 | −253 | −32 | −0 |
| Net financials | 0 | 0 | 0 | −4 | −1 | −8 | −8 | −4 | −11 | −1 | −0 |
| Profit before tax | −5 | −11 | 42 | −42 | −57 | −507 | −18 | −54 | −264 | −33 | −0 |
| Tax | −0 | −0 | 7 | 0 | 0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −5 | −11 | 35 | −42 | −58 | −507 | −18 | −54 | −264 | −33 | −0 |
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 100 | 100 | 136 | 139 | 305 | 310 | 171 | 142 | 167 | 166 | 166 |
| Equity | 95 | 84 | 118 | 76 | 19 | −488 | −506 | −561 | −825 | −857 | −858 |
| Long-term debt | 0 | 8 | 8 | 0 | 0 | 263 | 565 | 590 | 772 | 1 003 | 1 006 |
| Short-term debt | 5 | 8 | 9 | 63 | 287 | 536 | 113 | 113 | 220 | 21 | 18 |
| Total debt | 5 | 16 | 17 | 63 | 287 | 799 | 677 | 703 | 991 | 1 024 | 1 024 |
EBITDA margin
-37400.0%
This company
15.8%
Market median
-236809% vs market
20102020
Equity ratio
-515.4%
This company
38.2%
Market median
-1449% vs market
20102020
Return on equity
-37600.0%
This company
18.4%
Market median
-204448% vs market
20102020
Net profit margin
-37600.0%
This company
8.1%
Market median
-464298% vs market
20102020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20102020
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20102020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-03-20 – 2010-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FULMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svenn Rommerud | Chairman | 0 companies |
| Henrik Johan Rommerud | Board of Directors | 0 companies |